march
wisconsin
divis
public
health
notifi
possibl
respiratori
syncyti
viru
rsv
infect
outbreak
among
infant
hospit
neonat
intens
care
unit
nicu
march
index
patient
neonat
age
day
feed
intoler
apnea
nasopharyng
swab
specimen
collect
neonat
test
use
singlemanufactur
rapid
rsv
antigen
detect
test
rradt
hospit
laboratori
result
posit
follow
day
concern
possibl
widespread
rsv
infect
rradt
use
test
nasopharyng
swab
specimen
neonat
b
age
month
resid
differ
hospit
room
nicu
develop
increas
oxygen
requir
apnea
poor
feed
day
well
two
asymptomat
neonat
hospit
room
neonat
three
posit
later
day
nasopharyng
swab
specimen
remain
asymptomat
nicu
patient
test
use
rradt
seven
test
posit
make
total
posit
rradt
perform
hospit
laboratori
march
nasopharyng
specimen
sent
wisconsin
state
laboratori
hygien
confirmatori
test
use
multiplex
respiratori
viru
realtim
polymeras
chain
reaction
pcr
panel
esensor
genmark
diagnost
inc
target
virus
includ
rsv
subgroup
b
sixteen
nasopharyng
specimen
neg
viru
target
three
posit
rsva
includ
specimen
neonat
b
one
asymptomat
neonat
whose
rradt
result
posit
nasopharyng
swab
specimen
one
asymptomat
neonat
posit
rradt
test
posit
human
coronaviru
pcr
nasopharyng
specimen
pcr
result
confirm
cdc
therefor
among
specimen
rsvneg
pcr
eight
posit
rradt
falseposit
rate
sensit
percentag
person
diseas
posit
test
specif
percentag
person
without
diseas
neg
test
rradt
detect
rsv
characterist
test
howev
test
result
interpret
depend
posit
predict
valu
ppv
ie
proport
testposit
patient
rsv
infect
influenc
rsv
infect
preval
studi
among
infant
young
children
symptom
consist
respiratori
ill
peak
rsv
season
late
januari
march
demonstr
sensit
specif
ppv
rradt
respect
howev
report
ppv
test
might
applic
patient
test
dissimilar
popul
evalu
determin
ppv
case
ppv
test
use
symptomat
infant
might
necessarili
appli
asymptomat
infant
even
test
peak
rsv
season
possibl
contributor
high
rate
fals
posit
includ
contamin
viral
transport
media
appli
topic
prepar
emolli
neonat
nare
aliquot
infant
nasopharyng
specimen
provid
rradt
manufactur
without
person
identifi
inform
valid
verif
test
specimen
conduct
manufactur
hospit
laboratori
rradt
result
replic
conclus
investig
wisconsin
divis
public
health
recommend
facil
rradt
use
test
symptomat
neonat
accord
manufactur
guidelin
addit
divis
recommend
posit
rradt
result
confirm
realtim
pcr
would
detect
rsv
b
diagnost
test
indic
use
patient
characterist
clinic
ill
might
produc
mislead
result
use
anoth
purpos
screen
asymptomat
patient
march
wisconsin
divis
public
health
notifi
possibl
respiratori
syncyti
viru
rsv
infect
outbreak
among
infant
hospit
neonat
intens
care
unit
nicu
march
index
patient
neonat
age
day
feed
intoler
apnea
nasopharyng
swab
specimen
collect
neonat
test
use
singlemanufactur
rapid
rsv
antigen
detect
test
rradt
hospit
laboratori
result
posit
follow
day
concern
possibl
widespread
rsv
infect
rradt
use
test
nasopharyng
swab
specimen
neonat
b
age
month
resid
differ
hospit
room
nicu
develop
increas
oxygen
requir
apnea
poor
feed
day
well
two
asymptomat
neonat
hospit
room
neonat
three
posit
later
day
nasopharyng
swab
specimen
remain
asymptomat
nicu
patient
test
use
rradt
seven
test
posit
make
total
posit
rradt
perform
hospit
laboratori
march
nasopharyng
specimen
sent
wisconsin
state
laboratori
hygien
confirmatori
test
use
multiplex
respiratori
viru
realtim
polymeras
chain
reaction
pcr
panel
esensor
genmark
diagnost
inc
target
virus
includ
rsv
subgroup
b
sixteen
nasopharyng
specimen
neg
viru
target
three
posit
rsva
includ
specimen
neonat
b
one
asymptomat
neonat
whose
rradt
result
posit
nasopharyng
swab
specimen
one
asymptomat
neonat
posit
rradt
test
posit
human
coronaviru
pcr
nasopharyng
specimen
pcr
result
confirm
cdc
therefor
among
specimen
rsvneg
pcr
eight
posit
rradt
falseposit
rate
sensit
percentag
person
diseas
posit
test
specif
percentag
person
without
diseas
neg
test
rradt
detect
rsv
characterist
test
howev
test
result
interpret
depend
posit
predict
valu
ppv
ie
proport
testposit
patient
rsv
infect
influenc
rsv
infect
preval
studi
among
infant
young
children
symptom
consist
respiratori
ill
peak
rsv
season
late
januari
march
demonstr
sensit
specif
ppv
rradt
respect
howev
report
ppv
test
might
applic
patient
test
dissimilar
popul
evalu
determin
ppv
case
ppv
test
use
symptomat
infant
might
necessarili
appli
asymptomat
infant
even
test
peak
rsv
season
possibl
contributor
high
rate
fals
posit
includ
contamin
viral
transport
media
appli
topic
prepar
emolli
neonat
nare
aliquot
infant
nasopharyng
specimen
provid
rradt
manufactur
without
person
identifi
inform
valid
verif
test
specimen
conduct
manufactur
hospit
laboratori
rradt
result
replic
conclus
investig
wisconsin
divis
public
health
recommend
facil
rradt
use
test
symptomat
neonat
accord
manufactur
guidelin
addit
divis
recommend
posit
rradt
result
confirm
realtim
pcr
would
detect
rsv
b
diagnost
test
indic
use
patient
characterist
clinic
ill
might
produc
mislead
result
use
anoth
purpos
screen
asymptomat
patient
